A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
Clinical trial NCT05262959 · COMPLETED
Trial details
- NCT number
- NCT05262959
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.